Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
A Review on Leukemia and Ipsc Technology: Application in Novel Treatment and Future Publisher Pubmed



Maali A1 ; Atashi A2 ; Ghaffari S3 ; Kouchaki R4 ; Abdolmaleki F4 ; Azad M4
Authors

Source: Current Stem Cell Research and Therapy Published:2018


Abstract

Leukemia is an uncontrollable growth of hematopoietic cells due to a mutation in DNA followed by cellular dysregulation and one or more chromosomal disorder that generally leads to a clonal abnormality. Theoretical and technical inability in early screening and distinguishing cancer, tumor tolerance to common treatment methods, repeated relapses of cancer after remission phase, heterogeneous chromosomal abnormality, and the side effects of current chemotherapies are some of challenges that we face with leukemia and other malignancies. Induced pluripotent stem cells (iPSC) opened a promising window to a wide range of diseases, including leukemia. Overcoming the barriers in leukemia is possible with iPSC technology. Induced hematopoietic stem cell transplantation (and gene therapy), induced cytotoxic T-lymphocytes and reprogrammed NK cells that strengthen the immune system, miRNAs, modeling approaches, and supportive cares are some aspects of the novel treatment based on iPSC technology. © 2018 Bentham Science Publishers.
Related Docs
View other Related Docs
1. Toward in Vitro Production of Platelet From Induced Pluripotent Stem Cells, Stem Cell Reviews and Reports (2022)
2. Induced Pluripotent Stem Cell Meets Severe Combined Immunodeficiency, Cell Journal (2020)
3. Induced Pluripotent Stem Cells As a New Getaway for Bone Tissue Engineering: A Systematic Review, Cell Proliferation (2017)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (4)
Javad Verdi (2)
Other Related Docs
4. Reprogramming of Endometrial Adult Stromal Cells in the Presence of a Rock Inhibitor, Thiazovivin, Could Obtain More Efficient Ipscs, Cell Biology International (2015)
5. Applied Induced Pluripotent Stem Cells in Combination With Biomaterials in Bone Tissue Engineering, Journal of Cellular Biochemistry (2017)
6. Applications of Innovation Technologies for Personalized Cancer Medicine: Stem Cells and Gene-Editing Tools, ACS Pharmacology and Translational Science (2023)
7. Immunotherapy of Cancers Comes of Age, Expert Review of Clinical Immunology (2017)
8. Cancer Cells As a New Source of Induced Pluripotent Stem Cells, Stem Cell Research and Therapy (2022)
9. Promotion of Cell-Based Therapy: Special Focus on the Cooperation of Mesenchymal Stem Cell Therapy and Gene Therapy for Clinical Trial Studies, Advances in Experimental Medicine and Biology (2018)
10. Cell Transfer-Based Immunotherapies in Cancer: A Review, IUBMB Life (2020)
11. Stem Cells Have More Than Five Senses, Biophysics and Neurophysiology of the Sixth Sense (2019)
12. Cell Therapy Using Embryonic Stem Cell Source in Clinical Trial Studies: Advantages and Limitations, Journal of Mazandaran University of Medical Sciences (2017)
13. Generation of Induced Pluripotent Cancer Cells From Glioblastoma Multiform Cell Lines, Cellular Reprogramming (2019)
14. Combining the Induced Pluripotent Stem Cell (Ipsc) Technology With Chimeric Antigen Receptor (Car)-Based Immunotherapy: Recent Advances, Challenges, and Future Prospects, Frontiers in Cell and Developmental Biology (2024)
15. Immunotherapeutic Approaches in Cancer, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2019)
16. Immunotherapeutic Approaches in Cancer, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2018)
17. Genetically-Modified Stem Cell in Regenerative Medicine and Cancer Therapy; a New Era, Current Gene Therapy (2022)
18. Therapy of Endocrine Disease: Islet Transplantation for Type 1 Diabetes: So Close and yet so Far Away, European Journal of Endocrinology (2015)
19. Cancer Immunotherapy Via Stem Cell-Derived Nk Cells, Immunotherapy (2023)
20. Potential Therapeutic Roles of Natural Killer Cells in Acute Myeloid Leukemia: A Systematic Review Study, Clinical and Experimental Medicine (2025)